AgendaSaturday, September 13, 2025

7:30 AM - 7:50 AM

Registration and Breakfast

8:00 AM - 8:10 AM

Opening Remarks

by Moderator Joseph F. Goldberg, MD

8:10 AM - 9:10 AM

Preventing Manic Relapse in Bipolar I: The Value of Lithium and LAI Antipsychotics

Presented by Jonathan M. Meyer, MD, DLFAPA

Overview up-to-date evidence for safe and effective maintenance antimania therapies in bipolar I disorder, including lithium, mood stabilizers, and antipsychotic agents, with an eye toward optimizing patient engagement and treatment adherence.

9:10 AM - 9:20 AM

Break

9:20 AM - 10:20 AM

Empowering Treatment Choice With SPRAVATO®. “Empowering Treatment Choice With SPRAVATO®” is an educational program focusing on care options for adult patients with treatment-resistant depression (TRD).

 

  • Review the patient experience and unmet need in treatment-resistant depression (TRD)—major depressive disorder (MDD) with inadequate response to at least 2 oral antidepressants of adequate dose and duration
  • Understanding the mechanism of action for SPRAVATO® (esketamine) CIII nasal spray
  • Clinical efficacy data in TRD for SPRAVATO® alone or in combination with an oral antidepressant
  • 5-year results from a long-term, open-label safety study of SPRAVATO®
  • Two ways to connect patients to care with SPRAVATO®: treat or refer
  • Important Safety Information

 

This session is sponsored by Johnson & Johnson.

Presented by Brittany Albright, MD and Chet Robachinski, MD

Non-CME Educational Session, managed by Clinical Care Solutions, a CEA Company

10:20 AM - 10:30 AM

Break

10:30 AM - 11:30 AM

Warding Off Winter Woes: Strategies for Seasonal Affective Disorder (SAD) Support

Presented by Lisa Harding, MD

Shed light on seasonal affective disorder by strengthening your skills in its timely diagnosis and effective management. This program provides a comprehensive review of diagnostic criteria to distinguish SAD from other mood disorders and explores the evidence behind first-line interventions. Equip yourself with the expertise to confidently implement a range of treatments, from light therapy and psychotherapy to pharmacologic options, offering patients targeted relief and a brighter outlook year-round.

11:30 AM - 11:40 AM

Break

11:40 AM - 12:40 PM

Serious Reactions to Mood Disorder Treatments

Presented by Stanley N. Caroff, MD

Although there is an expanding toolbox of effective treatments for mood disorders, no treatment is without risks. This session covers rare, life-threatening reactions during treatment, focusing on neuroleptic malignant syndrome and serotonin syndrome. Best practices include careful monitoring informed by knowledge of adverse signs to facilitate rapid diagnosis and treatment.

12:40 PM - 1:10 PM

Break & Lunch for in-person attendees

1:10 PM - 2:10 PM

When Attention Meets Emotion: Managing Comorbid ADHD and Mood Disorders

Presented by Ann Childress, MD, DLFAPA

Many patients with mood disorders also have undiagnosed ADHD, increasing morbidity and likelihood of treatment failure. This session will explore the prevalence and impact of ADHD comorbidity with mood disorders and discuss best practices for assessment and symptom management in your patients.

2:10 PM - 2:20 PM

Break

2:20 PM - 3:20 PM

The Last Mile in MDD Treatment: Fine-tuning Remission Strategies for Residual Symptoms

Presented by Chuck DeBattista, DMH, MD

Go beyond initial treatment success by tackling the critical, often-overlooked challenge of residual symptoms in major depressive disorder that prevent patients from achieving true wellness. This program offers valuable insights into identifying and managing persistent symptoms that impact daily functioning and increase the risk of relapse. Explore advanced, evidence-based strategies designed to help your patients achieve an optimal quality of life and complete functional recovery.

3:20 PM - 3:30 PM

Closing Remarks

by Moderator Joseph F. Goldberg, MD